{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T06:28:37Z","timestamp":1756189717882,"version":"3.37.3"},"reference-count":25,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2021,4,27]]},"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1136\/ejhpharm-2021-002785","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T17:37:01Z","timestamp":1622741821000},"page":"53-56","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Biological therapy for ocular Beh\u00e7et\u2019s disease with off-label drug prescription in Turkey"],"prefix":"10.1136","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0558-5576","authenticated-orcid":false,"given":"Mehmet","family":"Citirik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cemile","family":"Ucgul Atilgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanife","family":"Rahmanlar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Alkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakki","family":"Gursoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"2024102217112262000_30.1.53.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0802107"},{"key":"2024102217112262000_30.1.53.2","first-page":"153","article-title":"Legal liability of the drug manufacturer and physician for damages arising from off-label drug use","volume":"8","author":"B\u00fcy\u00fcktan\u0131r","year":"2017","journal-title":"Inonu \u00dcniversitesi Hukuk Fak\u00fcltesi Dergisi"},{"key":"2024102217112262000_30.1.53.3","first-page":"121","article-title":"Off label treatment and the situation at world","volume":"8","author":"Y\u00fczba\u015f\u0131o\u011flu","year":"2015","journal-title":"Turkiye Klinikleri J Ophthalmol"},{"key":"2024102217112262000_30.1.53.4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089324"},{"key":"2024102217112262000_30.1.53.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.03.022"},{"key":"2024102217112262000_30.1.53.6","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2013.866257"},{"key":"2024102217112262000_30.1.53.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199002013220501"},{"key":"2024102217112262000_30.1.53.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400425"},{"key":"2024102217112262000_30.1.53.9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Beh\u00e7et's disease","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"key":"2024102217112262000_30.1.53.10","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.76.4.241"},{"key":"2024102217112262000_30.1.53.11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4274\/tjo.galenos.2019.60308","article-title":"Beh\u00e7et's uveitis: current diagnostic and therapeutic approach","volume":"50","author":"\u00c7akar \u00d6zdal","year":"2020","journal-title":"Turk J Ophthalmol"},{"key":"2024102217112262000_30.1.53.12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.31832\/smj.543998","article-title":"Off-label drug use in patients with diabetic retinopathy in Turkey","volume":"9","author":"Rahmanlar","year":"2019","journal-title":"Sakarya Med J"},{"key":"2024102217112262000_30.1.53.13","first-page":"249","article-title":"Off-label drug use in patients with age-related macular degeneration in Turkey","volume":"8","author":"Rahmanlar","year":"2010","journal-title":"Nam\u0131k Kemal T\u0131p Dergisi"},{"key":"2024102217112262000_30.1.53.14","first-page":"414","article-title":"Uber rezideiverende, aphth\u00f6se, durche in virus verursachte Geschw\u00fcre am mund, am Augeund an den Genitalien","volume":"46","author":"Beh\u00e7et","year":"1937","journal-title":"Dermatol Wochen schr"},{"key":"2024102217112262000_30.1.53.15","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.124875"},{"key":"2024102217112262000_30.1.53.16","first-page":"820","article-title":"The prevalence of Beh\u00e7et's syndrome in a rural area in northern Turkey","volume":"15","author":"Yurdakul","year":"1988","journal-title":"J Rheumatol"},{"key":"2024102217112262000_30.1.53.17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/14728214.2020.1847271","article-title":"Beh\u00e7et's disease uveitis: is there a need for new emerging drugs?","volume":"25","author":"Tugal-Tutkun","year":"2020","journal-title":"Expert Opin Emerg Drugs"},{"key":"2024102217112262000_30.1.53.18","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.4.423"},{"key":"2024102217112262000_30.1.53.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-006-0346-y"},{"key":"2024102217112262000_30.1.53.20","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/art.41026","article-title":"Comparative study of infliximab versus adalimumab in refractory uveitis due to Beh\u00e7et's disease: national multicenter study of 177 cases","volume":"71","author":"Atienza-Mateo","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2024102217112262000_30.1.53.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2015.06.004"},{"key":"2024102217112262000_30.1.53.22","first-page":"808","article-title":"Update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome","volume":"2018","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2024102217112262000_30.1.53.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.09.048"},{"key":"2024102217112262000_30.1.53.24","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.ophtha.2018.02.020","article-title":"Successful optimization of adalimumab therapy in refractory uveitis due to Beh\u00e7et's disease","volume":"125","author":"Mart\u00edn-Varillas","year":"2018","journal-title":"Ophthalmology"},{"key":"2024102217112262000_30.1.53.25","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu266"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2021-002785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:13:42Z","timestamp":1729642422000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2021-002785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,19]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1136\/ejhpharm-2021-002785"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2021-002785","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"type":"print","value":"2047-9956"},{"type":"electronic","value":"2047-9964"}],"subject":[],"published":{"date-parts":[[2021,6,3]]}}}